Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M369Revenue $M8.0Net Margin (%)-434.9Z-Score-5.7
Enterprise Value $M314EPS $-0.7Operating Margin %-399.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-434.9Higher ROA y-yY
Price/Book14.210-y EBITDA Growth Rate %-41.4Quick Ratio1.9Cash flow > EarningsN
Price/Sales40.25-y EBITDA Growth Rate %-29.4Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-85.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.2ROI % (ttm)-267.8Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSJean-Marie Eveillard 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 5.8515%New holding, 200000 sh.200,000
SNSSJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 5.8512%Sold Out0
SNSSJean-Marie Eveillard 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 5.8565%Reduce -30.24%350,000
SNSSJean-Marie Eveillard 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 5.85110%New holding, 501727 sh.501,727
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNSS Jean-Marie Eveillard 2014-03-31219,5570.360-8.5%
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ketchum Steven BDirector 2013-11-08Sell30,054$5.0513.66view

Press Releases about SNSS :

    Quarterly/Annual Reports about SNSS:

    News about SNSS:

    Articles On GuruFocus.com
    comment on SNSS Mar 02 2013 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
    cooldecency99 note on SNSS May 01 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
    Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
    Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
    Sunesis Reports Financial Results for the Second Quarter 2009 Jul 29 2009 

    More From Our Partners
    Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog Jul 14 2014 - ZACKS

    More From Other Websites
    Sunesis' Pediatric Plan Accepted in the EU Jul 14 2014
    Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation... Jul 09 2014
    Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation... Jul 09 2014
    Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation... Jul 09 2014
    Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session Jun 13 2014
    Coverage initiated on Sunesis Pharma by UBS Jun 12 2014
    Sunesis to Present at the 2014 Wells Fargo Healthcare Conference Jun 11 2014
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 09 2014
    Sunesis says encouraged by trial of Qinprezo Jun 02 2014
    Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial... Jun 02 2014
    Nasdaq stocks posting largest percentage increases May 20 2014
    SUNESIS PHARMACEUTICALS INC Financials May 16 2014
    Sunesis to Present at Upcoming Investor Conferences May 14 2014
    Sunesis Pharmaceuticals Inc Stock Downgraded (SNSS) May 09 2014
    Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q1 2014 Results - Earnings Call Transcript May 07 2014
    Sunesis Pharmaceuticals, Inc. Earnings Call scheduled for 11:00 am ET today May 07 2014
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 07 2014
    Q1 2014 Sunesis Pharmaceuticals, Inc. Earnings Release - Before Market Open May 07 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide